BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 7926452)

  • 1. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of zinc deficiency in development of hepatic encephalopathy in patients with liver cyrrosis].
    Shaposhnikova NA
    Eksp Klin Gastroenterol; 2007; (3):108-12. PubMed ID: 17937015
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic indicators in patients with liver cirrhosis admitted to an intensive care unit].
    Castera L; Pauwels A; Lévy VG
    Gastroenterol Clin Biol; 1996; 20(3):263-8. PubMed ID: 8763065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between zinc, amino acids and ammonia in liver cirrhosis.
    Grüngreiff K; Presser HJ; Franke D; Lössner B; Abicht K; Kleine FD
    Z Gastroenterol; 1989 Dec; 27(12):731-5. PubMed ID: 2626852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis.
    Rahelić D; Kujundzić M; Romić Z; Brkić K; Petrovecki M
    Coll Antropol; 2006 Sep; 30(3):523-8. PubMed ID: 17058518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolactin and estradiol levels in the plasma of patients with hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; Zúñiga Pérez-Lemaur M; Valle Cagigas M; Leno Valencia L
    Rev Clin Esp; 1985 Jan; 176(1):13-7. PubMed ID: 2986206
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum viscosity and chronic hepatopathies].
    Pavanel S; Dell'Anna L; Cappelletti P
    Quad Sclavo Diagn; 1983 Mar; 19(1):98-112. PubMed ID: 6675048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Zinc and alcoholic liver cirrhosis].
    Floriani M; Genga A; Spalluto A
    G Clin Med; 1988 May; 69(5):341-5. PubMed ID: 3169462
    [No Abstract]   [Full Text] [Related]  

  • 9. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
    Marchesini G; Fabbri A; Bianchi G; Brizi M; Zoli M
    Hepatology; 1996 May; 23(5):1084-92. PubMed ID: 8621138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of zinc deficiency on effectiveness of the treatment of liver encephalopathy in patients with liver cirrhoses].
    Shaposhnikova NA; Drozdov VN; Petrakov AV; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2007; (5):46-50, 164. PubMed ID: 18389597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy.
    Güven K; Kelestimur F; Yücesoy M
    Eur J Med; 1993 Feb; 2(2):83-5. PubMed ID: 8258022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis.
    Alvarez-Leal M; Contreras-Hernández D; Chávez A; Diaz-Contreras JA; Careaga-Olivares J; Zúñiga-Charles MA; Reynoso MC; Hernández-Téllez A
    Am J Hum Biol; 2001; 13(3):297-300. PubMed ID: 11460894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis.
    Flisiak R; Pytel-Krolczuk B; Prokopowicz D
    Cytokine; 2000 Jun; 12(6):677-81. PubMed ID: 10843744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
    Quero JC; Hartmann IJ; Meulstee J; Hop WC; Schalm SW
    Hepatology; 1996 Sep; 24(3):556-60. PubMed ID: 8781324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
    Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
    Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thrombopoietin levels in thrombocytopenic patients with liver cirrhosis.
    Vyzantiadis T; Theodoridou S; Giouleme O; Evgenidis N; Vyzantiadis A; Garipidou V
    Haematologica; 2002 Aug; 87(8):890-1. PubMed ID: 12161370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.